Stay updated with breaking news from Nasdaq Blu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BELLUS Health (NASDAQ:BLU – Get Rating) and GH Research (NASDAQ:GHRS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Insider and Institutional Ownership 90.1% of BELLUS Health shares […]
Lifesci Capital lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) from an outperform rating to a market perform rating in a report released on Tuesday morning, Marketbeat.com reports. Several other analysts have also recently weighed in on the company. Evercore ISI cut BELLUS Health to an outperform rating in a report on Tuesday. HC […]
Evercore ISI lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) to an outperform rating in a research report report published on Tuesday morning, The Fly reports. A number of other research analysts have also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $20.00 price target on shares […]
BELLUS Health (NASDAQ:BLU – Get Rating) was downgraded by stock analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report issued on Tuesday, The Fly reports. BLU has been the subject of a number of other research reports. HC Wainwright reiterated a “buy” rating and set a […]
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $14.43 and last traded at $14.43, with a volume of 67857446 shares changing hands. The stock had previously closed at $7.26. Analyst Ratings Changes Several equities analysts have issued reports on […]